Step by Step DIABETES IN PREGNANCY

Step-by-Step: Diabetes in Pregnancy

Diabetes in pregnancy is a common medical disorder that can significantly affect maternal and fetal outcomes if not identified and managed appropriately. It includes pre-gestational diabetes mellitus (Type 1 or Type 2 diabetes existing before pregnancy) and gestational diabetes mellitus (GDM), which is glucose intolerance first recognized during pregnancy. A systematic, step-by-step approach is essential for optimal care.

Step 1: Understanding the Pathophysiology

Pregnancy is a diabetogenic state due to increased insulin resistance caused by placental hormones such as human placental lactogen, cortisol, progesterone, and prolactin. These hormones antagonize insulin action, especially in the second and third trimesters. In women with limited pancreatic reserve, this leads to hyperglycemia. Pre-existing diabetes poses higher risks because hyperglycemia may already be present during organogenesis.

Step 2: Risk Assessment and Screening

All pregnant women should undergo screening for diabetes. Risk factors include obesity, advanced maternal age, family history of diabetes, previous macrosomic baby, unexplained stillbirth, polycystic ovarian syndrome, and prior GDM.

Screening is usually performed between 24–28 weeks of gestation. Commonly used methods include:

• One-step method: 75 g oral glucose tolerance test (OGTT)

• Two-step method: 50 g glucose challenge test followed by 100 g OGTT if abnormal

Early screening in the first trimester is recommended for high-risk women to detect pre-gestational diabetes.

Step 3: Diagnosis

Gestational diabetes is diagnosed when blood glucose values exceed defined thresholds during OGTT. Diagnostic criteria vary slightly by guidelines, but elevated fasting, 1-hour, or 2-hour plasma glucose values confirm the diagnosis.

Pre-gestational diabetes is diagnosed using standard criteria such as:

• Fasting plasma glucose ≥126 mg/dL

• HbA1c ≥6.5%

• Random plasma glucose ≥200 mg/dL with symptoms

Step 4: Maternal and Fetal Assessment

Once diabetes is diagnosed, thorough evaluation is required.

Maternal assessment includes baseline investigations such as HbA1c, renal function tests, thyroid function, fundus examination, and blood pressure monitoring.

Fetal assessment involves early dating ultrasound, anomaly scan (especially important in pre-gestational diabetes), and serial growth scans in the third trimester to monitor fetal growth, amniotic fluid volume, and placental function.

Step 5: Medical Nutrition Therapy (MNT)

Dietary modification is the cornerstone of management, especially in gestational diabetes. The goals are to maintain euglycemia, provide adequate nutrition, and avoid ketosis.

Key dietary principles include:

• Small, frequent meals

• Controlled carbohydrate intake

• High fiber content

• Adequate protein and micronutrients

Weight gain should be individualized based on pre-pregnancy BMI. Many women with GDM can achieve glycemic control with diet and exercise alone.

Step 6: Physical Activity

Moderate physical activity such as walking for 30 minutes daily improves insulin sensitivity and helps maintain blood glucose levels. Exercise should be safe, non-strenuous, and tailored to the woman’s obstetric condition. Contraindications such as placenta previa or threatened preterm labor must be ruled out.

Step 7: Pharmacological Management

If lifestyle measures fail to achieve target glucose levels, pharmacotherapy is initiated.

• Insulin is the gold standard and preferred treatment, especially in pre-gestational diabetes.

• Oral hypoglycemic agents like metformin may be used in selected cases of GDM, depending on guidelines and patient acceptance.

Glycemic targets typically include:

• Fasting glucose <95 mg/dL

• 1-hour postprandial <140 mg/dL

• 2-hour postprandial <120 mg/dL

Step 8: Antenatal Monitoring

Pregnant women with diabetes require close follow-up. Blood glucose monitoring is done multiple times a day. Fetal surveillance includes non-stress tests, biophysical profiles, and Doppler studies in high-risk cases.

Complications such as preeclampsia, polyhydramnios, macrosomia, preterm labor, and infections should be actively monitored.

Step 9: Intrapartum Management

Timing and mode of delivery depend on glycemic control, fetal size, and obstetric factors. Well-controlled GDM pregnancies may go to term, while poorly controlled diabetes may require earlier delivery.

During labor, maternal blood glucose is monitored closely, and insulin infusion may be used to maintain euglycemia. Neonatal team preparedness is essential due to the risk of neonatal hypoglycemia.

Step 10: Postpartum Care and Long-Term Follow-Up

After delivery, insulin resistance rapidly decreases. Most women with GDM return to normal glucose levels, but they remain at high risk of developing Type 2 diabetes later in life.

Postpartum OGTT is recommended at 6–12 weeks after delivery. Lifestyle modification, breastfeeding, and long-term follow-up are strongly encouraged. Women with pre-gestational diabetes require continued diabetic care.

Conclusion

Diabetes in pregnancy requires a structured, step-by-step approach encompassing early detection, appropriate treatment, and vigilant monitoring. With optimal multidisciplinary care, most women can achieve favorable maternal and fetal outcomes. Early intervention not only improves pregnancy results but also plays a critical role in preventing future metabolic disease in both mother and child.